Coherus Oncology Inc
(CHRS)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 125,987 | 102,891 | 63,547 | 417,195 | 541,158 |
| Marketable Securities | 0 | 14,857 | 128,134 | 0 | N/A |
| Receivables | 122,334 | 260,522 | 109,964 | 123,022 | 157,046 |
| Inventories | 70,094 | 62,605 | 38,791 | 37,642 | 44,233 |
| Other current assets | 11,532 | 11,099 | 22,918 | 10,798 | 5,613 |
| TOTAL | $341,583 | $475,631 | $381,234 | $602,323 | $767,479 |
| Non-Current Assets | |||||
| PPE Net | 2,837 | 5,119 | 8,754 | 7,813 | 10,108 |
| Intangibles | 53,646 | 71,673 | 5,931 | 0 | 3,563 |
| Other Non-Current Assets | 50,467 | 77,181 | 84,928 | 69,198 | 60,499 |
| TOTAL | $106,950 | $153,973 | $99,613 | $77,011 | $74,170 |
| Total Assets | $448,533 | $629,604 | $480,847 | $679,334 | $841,649 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 28,456 | 35,219 | 11,526 | 16,159 | 15,201 |
| Accrued Expenses | 254,525 | 296,552 | 127,168 | 149,168 | 130,452 |
| TOTAL | $282,981 | $331,771 | $138,694 | $165,327 | $145,653 |
| Non-Current Liabilities | |||||
| Long Term Debt | 36,698 | 246,481 | 245,483 | 75,513 | 74,481 |
| Other Non-Current Liabilities | 260,844 | 244,777 | 234,088 | 340,768 | 340,541 |
| TOTAL | $297,542 | $491,258 | $479,571 | $416,281 | $415,022 |
| Total Liabilities | $580,523 | $823,029 | $618,265 | $581,608 | $560,675 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 115,897 | 112,715 | 79,610 | 77,275 | 72,794 |
| Common Shares | 12 | 11 | 8 | 7 | 7 |
| Retained earnings | -1,550,993 | -1,579,500 | -1,341,608 | -1,049,854 | -762,754 |
| Other shareholders' equity | -275 | -248 | -249 | -270 | -270 |
| TOTAL | $-131,990 | $-193,425 | $-137,418 | $97,726 | $280,974 |
| Total Liabilities And Equity | $448,533 | $629,604 | $480,847 | $679,334 | $841,649 |